JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2011, Vol. 49 ›› Issue (9): 117-.

• Articles • Previous Articles     Next Articles

Clinical comparison of psychotic major depression and non-psychotic major depression

WANG Xue-feng1, SONG Xiao1, TAN Lan2   

  1. 1. Department of Neurology, Rushan People′s Hospital Affiliated to Qingdao University Medical College,
    Rushan 264500, Shandong, China; 2. Department of Neurology, Qingdao Municipal Hospital Affiliated to
    Qingdao University Medical College, Qingdao 266071, Shandong, China
  • Received:2011-04-18 Online:2011-09-10 Published:2011-09-10

Abstract:

Objective   To compare psychotic major depression(PMD) and non-psychotic major depression(NMD) in clinical features, and treatment methods and effects. Methods   150 cases of severe depression were divided into the PMD group(100 cases) and the NMD group(50 cases). In the PMD group,  41 patients were treated with a single agent, and the other 59 patients were treated with combined agents. The NMD group and PMD mono-therapy group were treated with paroxetine, while the PMD combination therapy group was treated with a combination of oral paroxetine and olanzapine.  All groups were scored with the Hamilton Depression Rating Scale (HAMD) at the 1st visit and after 1,3 and 9 months of treatment. Results   ① HAMD total scores in NMD and PMD groups at the 1st visit were (53.22±6.00) and (58.30±5.20), respectively(P>0.05). The retardation factor, cognitive factor, and suicide factor in the PMD group were higher than those in the NMD group. ②After 9 months of treatment, the HAMD score in the PMD monotherapy group was higher than that in the PMD combination therapy group. The score in the PMD mono-therapy group was higher than in the NMD group. ③At the 1st test with the Pittsburgh Sleep Quality Index(PSQI), NMD and PMD had no significant difference in sleep disorders(P<0.05), while they were statistically different from the healthy controls. After 9 months of treatment, NMD and PMD were statistically improved in total scores and all the main factor scores (P<0.05), and they were still statistically different in first factors “subjective sleep quality” and “daytime dysfunction”, and the secondary factor “wake up at night or wake too early”. Conclusions    ①PMD is as serious as NMD. Retardation, cognitive impairment and suicidal thoughts in PMD patients are more obvious than those with NMD,while depression in NMD patients is more obvious.②For PMD, treatment with paroxetine and olanzapine is more effective than paroxetine alone. Compared with PMD patients, paroxetine monotherapy is more suitable for NMD patients.③Major depression has a decline in comprehensive sleep function. After effective treatment, sleep function can be significantly improved, but part of sleep dysfunction still remains. Mental symptoms cannot affect sleep function damage and recovery.

Key words:  Psychotic symptoms; Depression; Olanzapine; Paroxetine; Sleep disorders

CLC Number: 

  • R741
[1] YAO Yun-yi1, SUN Li2, XUE Jian-hong3, HOU Qian4, LIU Xiao-qun5, ZHOU Xiao-li5, YAN Hong-ying6, HONG Hua-rong7, YU Guo-qiang8, CHEN Fang1. Pathologic study on improvement of Alzheimer’s disease mice
treated with ethanol soluble extract of polygala
[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(11): 11-.
[2] ZHOU Bo1, WEN Min1, WANG Yun2, LONG Gao-qun3, QU Ting-nian3, LI Hong-wei1, JIAO Ling4, ZHANG Chun-lin3. Effect of Edaravone on autophagy in midbrain of Parkinson′s mice model [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(8): 1-4.
[3] MAN Xiao-xiao1, YU Jun2, WANG Xiao-yun1, LIU Zhen1, LUO Shan-shan1,XIE Zhao-hong1, ZHAO Cui-ping1, BI Jian-zhong1. Effect of xinmailong injection on proliferation and differentiation of
neural stem cells in the hippocampus of newborn rats
[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(6): 46-50.
[4] CAO Li-jun1, WANG Jin2, SUN Chun-li1, CHEN Yu-guo1. Mechanism and protective effect of ulinastatin on synaptic function of
hippocampus after focal brain ischemiareperfusion injury in rats
[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(2): 6-.
[5] JIA Li-yun1, PAN Xiao-hua2, LIU Jing1, CUI Xing3, WANG Mo-lin1. Protective effects of ginsenoside Rb1 and Re on  SK-N-SH cells injured by Aβ25-35 [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(4): 33-37.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!